Open Trials |
|
|
|
||
OvarAGO-PRO 1 / Symptom BenefitDoes Palliative Chemotherapy Improve Symptoms in Women with Recurrent Ovarian Cancer?
|
Download |
|
|
|
||
AGO-OVAR 17A prospective randomised Phase III trial to evaluate optimal treatment duration of first-line bevacizumab in combination with carboplatin and paclitaxel in patients with primary epithelial ovarian, fallopian tube or peritoneal cancer. The BOOST (Bevacizumab Ovarian Optimal Standard Treatment) Trial
|
Download |
|
|
||
Ovar/EndometriumAGO-GYN 8Efficacy, tolerability and safety of Temsirolimus in women with platinum-refractory ovarian carcinoma or advanced endometrial carcinoma
|
Download |
|
|
||
|
|
||
Clinical trials in surgical settings |
|
|
AGO-OVAR OP.4 / DESKTOP IIIA randomized multicenter study to compare the efficacy of additional tumor debulking surgery versus chemotherapy alone for recurrent platinum-sensitive ovarian cancer |
Download |
|